| scholarly article | Q13442814 |
| P2093 | author name string | Feng Li | |
| Nobuyuki Takahashi | |||
| Chih-Hong Wang | |||
| P2860 | cites work | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 |
| A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor | Q24297376 | ||
| Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin | Q24298747 | ||
| Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides | Q24309254 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice | Q28507336 | ||
| Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat | Q28583121 | ||
| Angiotensin converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme | Q28583658 | ||
| Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice | Q28586639 | ||
| Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes | Q28592947 | ||
| Angiotensinogen-deficient mice with hypotension | Q28594906 | ||
| The metabolic syndrome--a new worldwide definition | Q29615125 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| A genetically clamped renin transgene for the induction of hypertension | Q30453336 | ||
| The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains | Q31778105 | ||
| Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. | Q33593068 | ||
| ACE insertion/deletion genotype affects bradykinin metabolism | Q77227510 | ||
| AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy | Q77580246 | ||
| Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases | Q77804605 | ||
| Insulin sensitivity, clearance and release in kininogen-deficient rats | Q77856198 | ||
| Insulin sensitivity in patients with essential hypertension: no influence of the ACE inhibitor enalapril | Q78138825 | ||
| The ACE insertion/deletion polymorphism is not associated with the metabolic syndrome (WHO Definition) in Brazilian type 2 diabetic patients | Q78579871 | ||
| Haplotype analysis of the human renin gene and essential hypertension | Q78945499 | ||
| Association of angiotensin converting enzyme gene I/D polymorphism with type 2 diabetes mellitus | Q79254331 | ||
| Prorenin and the (pro)renin receptor--an update | Q79678982 | ||
| Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue | Q79696160 | ||
| Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension | Q80013636 | ||
| Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage | Q80050975 | ||
| Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure | Q80998610 | ||
| Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome | Q82678869 | ||
| Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice | Q83226595 | ||
| Metabolic syndrome: from epidemiology to systems biology | Q33691139 | ||
| The angiotensin II type 2 receptor: an enigma with multiple variations | Q33858658 | ||
| Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse | Q33949362 | ||
| The ACE I/D polymorphism and human physical performance. | Q34089011 | ||
| Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cells | Q34160753 | ||
| An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
| Genetic control of blood pressure and the angiotensinogen locus | Q34498129 | ||
| Physiology of local renin-angiotensin systems. | Q34543927 | ||
| Mast cell tryptases and chymases in inflammation and host defense | Q34627778 | ||
| Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. | Q34830604 | ||
| Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
| The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats | Q35028743 | ||
| Kinin B2 receptor is not involved in enalapril-induced apoptosis and regression of hypertrophy in spontaneously hypertensive rat aorta: possible role of B1 receptor | Q35046131 | ||
| ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy | Q35117583 | ||
| Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System | Q35127237 | ||
| Brain renin-angiotensin system. Lessons from functional genomics | Q35601029 | ||
| Human genetics, animal models and computer simulations for studying hypertension | Q35704389 | ||
| Insights into angiotensin II receptor function through AT2 receptor knockout mice | Q35850538 | ||
| Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury | Q35916066 | ||
| Angiotensin receptors: a new role in cancer? | Q36215159 | ||
| Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin | Q36326017 | ||
| The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy | Q36404461 | ||
| Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice | Q36458652 | ||
| Renin/prorenin receptors | Q36467820 | ||
| Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance | Q36638764 | ||
| Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism | Q36674722 | ||
| The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology | Q36733551 | ||
| The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function | Q36794938 | ||
| Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene | Q36853955 | ||
| Improvement of insulin sensitivity by antagonism of the renin-angiotensin system | Q36854401 | ||
| Aliskiren: a review of its use in the management of hypertension | Q36903748 | ||
| Genetically altered animal models for Mas and angiotensin-(1-7). | Q37044345 | ||
| The kallikrein-kinin system in health and in diseases of the kidney | Q37070150 | ||
| Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide | Q46796595 | ||
| Role of kinin B1 and B2 receptors in a rat model of neuropathic pain | Q46817593 | ||
| Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. | Q46966464 | ||
| Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity | Q47198714 | ||
| ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight | Q47401971 | ||
| Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients. | Q47682665 | ||
| A novel sequence polymorphism in the promoter region of the human B2-bradykinin receptor gene | Q48064536 | ||
| Prevention of adipose tissue depletion during food deprivation in angiotensin type 2 receptor-deficient mice | Q48436429 | ||
| Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice | Q48459993 | ||
| Involvement of the renin-angiotensin system in captopril-induced sodium appetite in the rat | Q48632077 | ||
| Targeting deletion of angiotensin type 1B receptor gene in the mouse | Q48786167 | ||
| Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia. | Q50514590 | ||
| Renin-1 Is Essential for Normal Renal Juxtaglomerular Cell Granulation and Macula Densa Morphology | Q50947288 | ||
| Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. | Q51014653 | ||
| Association between angiotensin-1 converting enzyme gene polymorphism and the metabolic syndrome in a Mexican population. | Q51468432 | ||
| Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes. | Q52014922 | ||
| Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice. | Q52576428 | ||
| Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. | Q52909701 | ||
| Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. | Q53629064 | ||
| Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension. | Q54080020 | ||
| Lifelong genetic minipumps. | Q54690266 | ||
| Cellular mechanism of vasoconstriction induced by angiotensin II: it remains to be determined. | Q55037922 | ||
| Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis | Q56893651 | ||
| Highly Regulated Cell Type-restricted Expression of Human Renin in Mice Containing 140- or 160-Kilobase Pair P1 Phage Artificial Chromosome Transgenes | Q56959216 | ||
| Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice | Q56963485 | ||
| Angiotensin converting enzyme insertion allele in relation to high altitude adaptation | Q57111274 | ||
| The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents | Q57243049 | ||
| Quantitated transcript haplotypes (QTH) ofAGTR1, reduced abundance of mRNA haplotypes containing 1166C (rs5186:A>C), and relevance to metabolic syndrome traits | Q57273802 | ||
| Insights derived from ACE knockout mice | Q57630554 | ||
| The Role of Angiotensin-Converting Enzyme in Blood Pressure Control, Renal Function, and Male Fertility | Q57630584 | ||
| Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II | Q58223924 | ||
| Association of (Pro)renin Receptor Gene Polymorphism With Blood Pressure in Japanese Men: The Ohasama Study | Q58363532 | ||
| Male–female differences in fertility and blood pressure in ACE-deficient mice | Q59055822 | ||
| Insertion/deletion polymorphism in the angiotensin-l-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy | Q61948435 | ||
| Role of the Angiotensin Type 2 Receptor Gene in Congenital Anomalies of the Kidney and Urinary Tract, CAKUT, of Mice and Men | Q63951732 | ||
| Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients | Q67553260 | ||
| Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats | Q71819533 | ||
| Targeted inactivation of the Ren-2 gene in mice | Q71853661 | ||
| Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects | Q72347776 | ||
| Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis | Q73086476 | ||
| Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension | Q73309662 | ||
| Late-onset obesity in mice transgenic for the human renin gene | Q73368124 | ||
| Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries | Q73556747 | ||
| Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy | Q73604842 | ||
| Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM | Q73922985 | ||
| The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics | Q74105791 | ||
| Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption | Q74326549 | ||
| Renal angiotensin II receptor regulation and renin-angiotensin system inhibition in one-kidney, one clip hypertensive rats | Q74586359 | ||
| The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM | Q74661798 | ||
| Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages | Q37122931 | ||
| eNOS, metabolic syndrome and cardiovascular disease. | Q37317509 | ||
| Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus | Q37342702 | ||
| (Pro)renin receptors: are they biologically relevant? | Q37349060 | ||
| A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro | Q37365783 | ||
| Structure, expression, and regulation of the murine renin genes | Q37377686 | ||
| Aliskiren: an oral direct renin inhibitor for the treatment of hypertension | Q37377943 | ||
| Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor | Q37513098 | ||
| Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. | Q38292812 | ||
| Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists | Q38312460 | ||
| A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity | Q38332479 | ||
| Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells | Q38347486 | ||
| The Brain Renin-Angiotensin System | Q40141478 | ||
| Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin | Q40176844 | ||
| Renin receptor expression in human adipose tissue | Q40188300 | ||
| Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. | Q40844226 | ||
| Angiotensin II--receptor subtypes characterization and pathophysiological implications. | Q40993834 | ||
| Differential expression of angiotensin receptor 1A and 1B in mouse | Q41449603 | ||
| Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes. | Q42525036 | ||
| PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin | Q42813848 | ||
| Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes | Q43299150 | ||
| Ren1d and Ren2 cooperate to preserve homeostasis: evidence from mice expressing GFP in place of Ren1d | Q43632146 | ||
| Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women | Q43653386 | ||
| Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. | Q44003398 | ||
| ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients | Q44007377 | ||
| Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta | Q44100854 | ||
| Transgenic study of the function of chymase in heart remodeling | Q44164798 | ||
| Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study | Q44269775 | ||
| Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature. | Q44329453 | ||
| Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease | Q44486184 | ||
| Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. | Q44568069 | ||
| Modulation of allergic and immune complex-induced lung inflammation by bradykinin receptor antagonists | Q44800109 | ||
| Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice | Q44810052 | ||
| The relation between obesity, abdominal fat deposit and the angiotensin-converting enzyme gene I/D polymorphism and its association with coronary heart disease. | Q45134470 | ||
| Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type | Q45162612 | ||
| Targeting kinin B(1) receptor for therapeutic neovascularization | Q45882818 | ||
| Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. | Q45919131 | ||
| Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. | Q45998990 | ||
| ACE insertion/deletion polymorphism and its relationships to the components of metabolic syndrome in elderly Slovaks. | Q46000711 | ||
| Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity? | Q46145636 | ||
| Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. | Q46290617 | ||
| Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes | Q46470676 | ||
| Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor | Q46477287 | ||
| Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity | Q46617665 | ||
| Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors | Q46696407 | ||
| Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys | Q46728725 | ||
| Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition | Q46743364 | ||
| The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease | Q46758647 | ||
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 1-13 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | The open hypertension journal | Q27723337 |
| P1476 | title | The renin angiotensin system and the metabolic syndrome. | |
| P478 | volume | 3 |
| Q34558074 | Angiotensin AT(2) receptor contributes towards gender bias in weight gain |
| Q91896482 | Antimetabolic Syndrome Effect of Phytosome Containing the Combined Extracts of Mulberry and Ginger in an Animal Model of Metabolic Syndrome |
| Q36521938 | Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia |
| Q51764431 | Correlation between the 24-h urinary angiotensinogen or aldosterone level and muscle mass: Japan shimanami health promoting program study. |
| Q42354239 | Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats |
| Q36228066 | Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade |
| Q37434424 | Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma |
| Q36208883 | High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats |
| Q41373148 | Hypoxia-induced proliferation in mesenchymal stem cells and angiotensin II-mediated PI3K/AKT pathway |
| Q35878038 | Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells |
| Q35234255 | The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II |
Search more.